base-edited hematopoietic stem and progenitor cells
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 17, 2024 (NCT06325709)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06959771 | Phase 1/Phase 2 (Phase 2) | Jul 16, 2025 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT06851767 | Phase 1/Phase 2 (Phase 2) | Mar 20, 2025 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT06325709 | Phase 1/Phase 2 (Phase 2) | Apr 17, 2024 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2024 |
1 organizations
Page 1 / 1